Fig. 7. Silencing of an expression site upon differentiation to the procyclic form is unaffected by loss of H3V. (A) Schematic diagram of telomere (zig-zag) proximal portion of the 221 expression site and the 221 expression site in which either GFP-BLE cassette or T7 promoter driven GFP-BLE was inserted. (B) Comparison of the GFP fluorescence intensity from the wild type (single marker), wild type + GFP (BFJEL36), wild type + T7-GFP (BFJEL37) and htv
/htv
(BFJEL25), htv
/htv
+ GFP (BFJEL38) and htv
/htv
+ T7-GFP (BFJEL39) bloodstream-form cell lines and the same cell lines following two weeks differentiation to the procyclic form.